SD
Subrata Dasgupta
About Subrata Dasgupta
Data last updated:
Subrata Dasgupta is a Director at Exuberance Pharmachem Private Limited (since 2023), Additional Director at Prudential Stock & Securities Ltd (since 2020) and Additional Director at Mercury Fund Management Company Ltd (since 2020), and holds 17 more current directorships. The companies operate in Pharma, Financial Services and Trading. The 6 current companies with reported revenue have a combined latest revenue of ₹3.15 Cr; the largest is Exuberance Pharmachem Private Limited at ₹3.05 Cr (FY 2024). Earlier, Subrata Dasgupta was a Director at Innova Biosystems Ltd (from 2013) and Additional Director at Aman Tieup Private Limited (from 2010) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Apr 2023 | 2023 | ₹3.05 Cr (FY 2024) | Active | |
| Additional Director | 01 Sep 2020 | 1994 | ₹4.7 Lakh (FY 2025) | Active | |
| Additional Director | 01 Sep 2020 | 1991 | ₹4.5 Lakh (FY 2025) | Active | |
| Additional Director | 01 Sep 2020 | 1995 | ₹56,689 (FY 2025) | Active | |
| Additional Director | 15 May 2019 | 1985 | ₹21,651 (FY 2022) | Active | |
| Additional Director | 01 Sep 2020 | 1985 | ₹1,050 (FY 2025) | Active | |
| Director | 15 May 2019 | 2011 | Active | ||
| Additional Director | 15 May 2019 | 2011 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Sep 2013 | 2005 | Strike Off | ||
| Additional Director | 30 Jun 2010 | 2007 | Strike Off | ||
| Additional Director | 15 May 2019 | 2011 | Strike Off | ||
| Additional Director | 02 Jul 2018 | 2013 | Strike Off | ||
| Additional Director | 15 May 2019 | 2011 | Strike Off | ||
| Additional Director | 15 May 2019 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Subrata Dasgupta
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subrata Dasgupta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subrata Dasgupta
Subrata Dasgupta currently holds 20 directorships: Exuberance Pharmachem Private Limited (Director, since 11 Apr 2023, revenue ₹3.05 Cr (FY 2024)); Prudential Stock & Securities Ltd (Additional Director, since 01 Sep 2020, revenue ₹4.7 Lakh (FY 2025)); Mercury Fund Management Company Ltd (Additional Director, since 01 Sep 2020, revenue ₹4.5 Lakh (FY 2025)); Ami Capital Markets Ltd (Additional Director, since 01 Sep 2020, revenue ₹56,689 (FY 2025)); Falma Laboratories Private Limited (Additional Director, since 15 May 2019, revenue ₹21,651 (FY 2022)); and 15 more.
Subrata Dasgupta was first appointed on 30 Jun 2010 as Additional Director at Aman Tieup Private Limited. The most recent appointment on record is 11 Apr 2023 at Exuberance Pharmachem Private Limited.
The 6 current companies of Subrata Dasgupta that report revenue have a combined latest revenue of ₹3.15 Cr: Exuberance Pharmachem Private Limited ₹3.05 Cr (FY 2024); Prudential Stock & Securities Ltd ₹4.7 Lakh (FY 2025); Mercury Fund Management Company Ltd ₹4.5 Lakh (FY 2025); Ami Capital Markets Ltd ₹56,689 (FY 2025); Falma Laboratories Private Limited ₹21,651 (FY 2022); and 1 more.
Subrata Dasgupta held 6 earlier board appointments: Innova Biosystems Ltd (Director, from 30 Sep 2013); Aman Tieup Private Limited (Additional Director, from 30 Jun 2010); Vab Natural Resources Private Limited (Additional Director, from 15 May 2019); Cohesive Advisory Services Private Limited (Additional Director, from 02 Jul 2018); Discovery Online Tuition Private Limited (Additional Director, from 15 May 2019); and 1 more.
The current boards of Subrata Dasgupta's companies include Subhas Banerjee (Exuberance Pharmachem Private Limited), Surendra M (Exuberance Pharmachem Private Limited), Venkata Lakshmi Narayana Bhaswanth Komaragiri (Exuberance Pharmachem Private Limited), Deepak Banthia (Prudential Stock & Securities Ltd), Dipankar Dasgupta (Prudential Stock & Securities Ltd), Deba Prasad Biswas (Mercury Fund Management Company Ltd), among others.